Evidence map›Paper›PMID 39152112›Full record

ArticleNature communications2024

Motor innervation directs the correct development of the mouse sympathetic nervous system.

Alek G Erickson, Alessia Motta, Maria Eleni Kastriti, Steven Edwards, Fanny Coulpier, Emy Théoulle, Aliia Murtazina, Irina Poverennaya, Daniel Wies, Jeremy Ganofsky and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alek G Erickson *Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-7110-9386
Alessia Motta *Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy.ORCID 0000-0002-1008-8347
Maria Eleni KastritiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0563-7399
Steven EdwardsDepartment of Applied Physics, KTH Royal Institute of Technology, Stockholm, Sweden.
Fanny CoulpierMondor Institute for Biomedical Research (IMRB), INSERM, Créteil, France.
Emy ThéoulleUniversity of Claude Bernard Lyon 1, MeLiS, CNRS, INSERM, NeuroMyoGene Institute, Lyon, France.
Aliia MurtazinaDepartment of Neuroscience, Biomedicum, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-1630-1855
Irina PoverennayaCenter for Brain Research, Department of Neuroimmunology, Medical University Vienna, Vienna, Austria.ORCID 0000-0003-2562-5632
Daniel WiesDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Jeremy GanofskyUniversity of Claude Bernard Lyon 1, MeLiS, CNRS, INSERM, NeuroMyoGene Institute, Lyon, France.ORCID 0000-0002-2361-7869
Giovanni CanuUniversity College London, Department of Ophthalmology London, London, UK.ORCID 0000-0002-3349-4479
Francois LallemendDepartment of Neuroscience, Biomedicum, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-5484-0011
Piotr TopilkoMondor Institute for Biomedical Research (IMRB), INSERM, Créteil, France.
Saida HadjabDepartment of Neuroscience, Biomedicum, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-7953-8396
Kaj FriedDepartment of Neuroscience, Biomedicum, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-9997-7078
Christiana RuhrbergUniversity College London, Department of Ophthalmology London, London, UK.ORCID 0000-0002-3212-9381
Quenten SchwarzCenter for Cancer Biology, University of South Australia, Adelaide, SA, Australia.ORCID 0000-0002-5958-4181
Valerie CastellaniUniversity of Claude Bernard Lyon 1, MeLiS, CNRS, INSERM, NeuroMyoGene Institute, Lyon, France.ORCID 0000-0001-9623-9312
Dario BonanomiDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy. bonanomi.dario@hsr.it.ORCID 0000-0003-4517-1244
Igor AdameykoDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. igor.adameyko@ki.se.ORCID 0000-0001-5471-0356

Funding

Signaling mechanisms underlying neural crest cell fate decisionsF32DE029662 · NIDCR · KAROLINSKA INSTITUTE · PI ERICKSON, ALEK G · 2021 to 2023
$219k
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) STEMMING-FROM-NERVEGiovanni Armenise-Harvard Foundation Career Development AwardNIDCR NIH HHS F32 DE029662Wellcome Trust
6 · The paper itself

Abstract

The sympathetic nervous system controls bodily functions including vascular tone, cardiac rhythm, and the "fight-or-flight response". Sympathetic chain ganglia develop in parallel with preganglionic motor nerves extending from the neural tube, raising the question of whether axon targeting contributes to sympathetic chain formation. Using nerve-selective genetic ablations and lineage tracing in mouse, we reveal that motor nerve-associated Schwann cell precursors (SCPs) contribute sympathetic neurons and satellite glia after the initial seeding of sympathetic ganglia by neural crest. Motor nerve ablation causes mispositioning of SCP-derived sympathoblasts as well as sympathetic chain hypoplasia and fragmentation. Sympathetic neurons in motor-ablated embryos project precociously and abnormally towards dorsal root ganglia, eventually resulting in fusion of sympathetic and sensory ganglia. Cell interaction analysis identifies semaphorins as potential motor nerve-derived signaling molecules regulating sympathoblast positioning and outgrowth. Overall, central innervation functions both as infrastructure and regulatory niche to ensure the integrity of peripheral ganglia morphogenesis.

Indexed as

Ganglia, SympatheticMotor NeuronsNeural CrestSchwann CellsSympathetic Nervous SystemAnimalsFemaleGanglia, SpinalMiceMice, TransgenicNeurogliaSemaphorinsSemaphorins

Identifiers

PMID39152112
PMCPMC11329663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.